Macquarie Group
LKFT icon

Macquarie Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Macquarie Group’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,076
Closed -$107K – 2473
2020
Q4 		$107K Sell
1,076
-4,217
-80% -$516K ﹤0.01% 1857
2020
Q3 		$751K Sell
5,293
-169
-3% -$28.2K ﹤0.01% 1305
2020
Q2 		$1.08M Sell
5,462
-529
-9% -$110K ﹤0.01% 1186
2020
Q1 		$1.17M Sell
5,991
-2,013
-25% -$433K ﹤0.01% 1052
2019
Q4 		$1.66M Buy
8,004
+910
+13% +$168K ﹤0.01% 1093
2019
Q3 		$1.08M Sell
7,094
-268
-4% -$43.9K ﹤0.01% 1192
2019
Q2 		$949K Sell
7,362
-508
-6% -$60.3K ﹤0.01% 1227
2019
Q1 		$927K Buy
7,870
+102
+1% +$10.3K ﹤0.01% 1213
2018
Q4 		$713K Buy
7,768
+202
+3% +$20.5K ﹤0.01% 1232
2018
Q3 		$851K Sell
7,566
-2,299
-23% -$243K ﹤0.01% 1239
2018
Q2 		$909K Buy
9,865
+1,170
+13% +$114K ﹤0.01% 1207
2018
Q1 		$867K Sell
8,695
-905
-9% -$97.6K ﹤0.01% 1217
2017
Q4 		$900K Buy
9,600
+963
+11% +$91.1K ﹤0.01% 1269
2017
Q3 		$879K Sell
8,637
-601
-7% -$52.5K ﹤0.01% 1256
2017
Q2 		$707K Buy
9,238
+156
+2% +$13.1K ﹤0.01% 1248
2017
Q1 		$783K Sell
9,082
-2,587
-22% -$186K ﹤0.01% 1232
2016
Q4 		$749K Buy
+11,669
New +$718K ﹤0.01% 1236
2016
Q2 		– Sell
-46,955
Closed -$1.96M – 1586
2016
Q1 		$1.96M Buy
46,955
+12,422
+36% +$576K ﹤0.01% 954
2015
Q4 		$2.17M Buy
34,533
+10,952
+46% +$560K ﹤0.01% 913
2015
Q3 		$960K Buy
+23,581
New +$1.36M ﹤0.01% 1146

Other funds holding LKFT

Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Ikarian Capital
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Macquarie Group's LKFT Position: Q1 2021 in Review

Macquarie Group sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2021, closing a stake of 1,076 shares — an estimated $107K sold.

Macquarie Group first reported a position in LKFT in Q3 2015 and held it in 20 quarters. The position peaked at $2.17M in Q4 2015. 132 funds tracked by Wall St. Rank hold LKFT as of Q1 2021.

  • Macquarie Group reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Macquarie Group sold 1,076 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2021, an estimated $107K.
  • Macquarie Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and held it in 20 quarters.
  • Macquarie Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.17M in Q4 2015.
  • 132 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2021.

Based on Macquarie Group's 13F filing for Q1 2021, filed 14 May 2021.